Related Experiment Video

Updated: Jul 16, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy

K Hoebe1, Z Jiang, P Georgel

  • 1Department of Immunology, IMM-31, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037 USA. bruce@scripps.edu.

Current Pharmaceutical Design
|November 15, 2006
PubMed

Insights

Toll-like receptors (TLRs) are key microbial sensors linked to potent inflammatory pathways. Modulating TLR signaling offers therapeutic potential for infections, cancers, and inflammatory diseases by targeting specific molecular pathways.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are critical sensors of microbial infection.
  • TLRs activate powerful inflammatory signaling pathways in mammals.
  • The dual role of TLRs in immunity and inflammation presents therapeutic opportunities.

Purpose of the Study:

  • To explore the potential of modulating Toll-like receptor (TLR) signaling for therapeutic benefit.
  • To identify specific molecular targets within TLR pathways for selective modulation.
  • To investigate whether TLR signaling can be stimulated to combat infections and cancer, or blocked to treat inflammatory conditions.

Main Methods:

  • Review of classical and reverse genetic analyses.
  • Analysis of TLR signaling pathways.
  • Identification of potential molecular checkpoints for therapeutic intervention.

Main Results:

  • TLRs represent significant targets for drug development due to their role in inflammation.
  • Selective modulation of TLR signaling may be feasible.
  • Genetic analyses provide insights into specific points for pathway intervention.

Conclusions:

  • Modulating TLR signaling holds promise for treating infections, neoplastic diseases, and inflammatory disorders.
  • Targeting specific molecular checkpoints within TLR pathways is crucial for therapeutic success.
  • Further research into selective TLR pathway modulation is warranted.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: